After a promising feasibility study showing the potential of its natural language processing models, MSK has ambitions to use them in patient care.

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

Outlook: The breakout season didn’t materialize and might not have even if Ryan didn’t miss the final eight weeks with a shoulder muscle strain. Still, he seems to be getting closer. Holding him back ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...

TEMPUS AI ($TEM) posted quarterly earnings results on Monday, February 24th. The company reported earnings of -$0.18 per share, beating estimates of -$0.20 by $0.02 ...

TEMPUS AI ($TEM) is expected to release its quarterly earnings data on Monday, February 24th after market close, per Finnhub. Analysts are expecting revenue of ...